\u2013 Egr. Dr.\u00a0Enrique Hausermann\u00a0<\/b><\/p>\n
President of Assogenerici<\/p>\n
\u2013 Egr. Dr.\u00a0Massimo Scaccabarozzi<\/b><\/p>\n
President Farmindustria<\/p>\n
\u2013 Dear Hon\u00a0Beatrice Lorenzin<\/b><\/p>\n
Minister of Health<\/p>\n
–\u00a0<\/span>Dear Senator\u00a0Emilia Grazia DeBiasi<\/b><\/p>\n President of the Senate Health Commission<\/p>\n <\/p>\n <\/p>\n <\/p>\n object:\u00a0Pharmaceutical Representatives, neologisms and contracts.<\/b><\/p>\n <\/p>\n For some time there has been a return to talk about the role of Pharmaceutical Representatives.<\/p>\n SIAR round table, Aboutpharma conference, Eyeforpharma report.<\/p>\n Among other things, we read that the profession (ISF) will not die out, but will go through a process of evolution or even transformation with new and more complex skills (?!) to meet the need to interact with stakeholders.<\/p>\n Charming words.<\/p>\n And the others that follow are equally fascinating\u2026 drivers, skills, public speaking, kam, ram, problem solving, share of voice.<\/p>\n All fill the mouth with obscure neologisms, strategically written in a non-Italian language, so as to be less understandable, such as to disorient, to make them appear credible and indisputable.<\/p>\n As a source of absolute truths.<\/p>\n A suspicion remains, which we keep inside because it's all ours, without uncertainties.<\/p>\n We are willing, as always, to accept all innovations that are proposed and requested, with only one limitation: we are not available, because it is not necessary, to review the contractual formulas.<\/p>\n These are defined, in fact, by a state law, as are our role and our responsibilities: we are happy to dialogue, interact, but not distort our work, which -commercial- must and cannot have anything.<\/p>\n We would be sorry if the various Squinzis wanted to leave Italy, but I can't help but respond as forty years of "apprenticeship" in the pharmaceutical industry at all levels of responsibility have taught me: we are all useful, no one is indispensable."<\/p>\n For every entrepreneur who stops doing business, others will propose.<\/p>\n These innovations made of nothing have been talked about for a long time these days and with a contemporaneity, which could also appear strategic, such as to make even SIAR, ABOUTPHARMA, EYEFORPHARMA of recognized seriousness and competence, and always esteemed by us, become suspicious.<\/p>\n The means are the new neologisms, but the end is always the same: a music that we know well.<\/p>\n It's good to understand, once and for all.<\/p>\n Because the times of barbarian invasions are over.<\/p>\n <\/p>\n <\/p>\n Fabio Carinci<\/b><\/p>\n FEDAIISF National President<\/b><\/p>","protected":false},"excerpt":{"rendered":" – Egr. Dott.\u00a0Enrique Hausermann\u00a0 Presidente Assogenerici – Egr. Dott.\u00a0Massimo Scaccabarozzi Presidente Farmindustria –\u00a0Gent.ma On.le\u00a0Beatrice Lorenzin Ministro della Salute –\u00a0Gent.ma Senatrice\u00a0Emilia Grazia De Biasi Presidente Commissione Sanit\u00e0 Senato oggetto:\u00a0Informatori Scientifici del Farmaco, neologismi e contratti. Da qualche tempo si torna a parlare del ruolo degli Informatori Scientifici del Farmaco. Tavola rotonda SIAR, …<\/p>","protected":false},"author":1,"featured_media":124,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,15],"tags":[],"class_list":["post-123","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-fedaiisf","category-news"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=123"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/123\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/124"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}